Deng Shuang, Ruan Yonghua, Bai Yao, Hu Yue, Deng Zeshuai, He Yongshu, Ruan Rui, Wu Yanrui, Yang Zhaoqing, Cui Liwang
Department of Pathogen Biology and Immunology, Kunming Medical University, Kunming, 650500, Yunnan Province, China.
Department of Pathology, Kunming Medical University, Kunming, 650500, Yunnan Province, China.
Malar J. 2016 Nov 4;15(1):528. doi: 10.1186/s12936-016-1592-z.
Plasmodium falciparum resistance to artemisinin emerged in the Greater Mekong Sub-region has been associated with mutations in the propeller domain of the kelch gene Pfk13.
Here the polymorphisms in Pvk12 gene, the orthologue of Pfk13 in Plasmodium vivax, were determined by PCR and sequencing in 262 clinical isolates collected in recent years (2012-2015) from the China-Myanmar border area.
Sequencing of full-length Pvk12 genes from these isolates identified three synonymous mutations (N172N, S360S, S697S) and one non-synonymous mutation M124I, all of which were at very low prevalence (2.0-3.1%). Moreover, these mutations were non-overlapping between the two study sites on both sides of the border. Molecular evolutionary analysis detected signature of purifying selection on Pvk12.
There is no direct evidence that Pvk12 is involved in artemisinin resistance in P. vivax, but it remains a potential candidate requiring further investigation. Continuous monitoring of potential drug resistance in this parasite is needed in order to facilitate the regional malaria elimination campaign.
在大湄公河次区域出现的恶性疟原虫对青蒿素的耐药性与kelch基因Pfk13的螺旋桨结构域中的突变有关。
在此,通过聚合酶链反应(PCR)和测序,对近年来(2012 - 2015年)从中国 - 缅甸边境地区收集的262份临床分离株中间日疟原虫的Pfk13直系同源基因Pvk12的多态性进行了测定。
对这些分离株的全长Pvk12基因进行测序,鉴定出三个同义突变(N172N、S360S、S697S)和一个非同义突变M124I,所有这些突变的发生率都非常低(2.0 - 3.1%)。此外,这些突变在边境两侧的两个研究地点之间不重叠。分子进化分析检测到对Pvk12的纯化选择特征。
没有直接证据表明Pvk12参与间日疟原虫对青蒿素的耐药性,但它仍然是一个需要进一步研究的潜在候选基因。为了推动区域疟疾消除运动,需要持续监测这种寄生虫的潜在耐药性。